Platinum Grove Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Platinum Grove Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$209K	Buy	+2,270	New	+$205K	0.69%	54

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Platinum Grove Asset Management's TMO Position: Q3 2013 in Review

Platinum Grove Asset Management opened a new position in Thermo Fisher Scientific (TMO) in Q3 2013: 2,270 shares worth $209K. The stake represents 0.69% of the portfolio and ranks #54 among its holdings.

817 funds tracked by Wall St. Rank hold TMO as of Q3 2013.

Platinum Grove Asset Management held 2,270 shares of Thermo Fisher Scientific worth $209K as of Q3 2013.
Thermo Fisher Scientific was a new Platinum Grove Asset Management position in Q3 2013.
Thermo Fisher Scientific made up 0.69% of Platinum Grove Asset Management's portfolio in Q3 2013, its #54 holding.
817 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2013.

Based on Platinum Grove Asset Management's 13F filing for Q3 2013, filed 13 Nov 2013.